Global (United States, European Union and China) Devices for Inhaled Medications Market Research Report 2019-2025

Table of Contents

1 Report Overview

• 1.1 Research Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Devices for Inhaled Medications Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Dry Powder Inhalers
  • 1.3.3 Metered-Dose Inhalers
  • 1.3.4 Nebulizers
  • 1.3.5 Soft Mist Inhaler
• 1.4 Market Segment by Application
  • 1.4.1 Global Devices for Inhaled Medications Market Share by Application (2019-2025)
  • 1.4.2 Clinic
  • 1.4.3 Hospital
  • 1.4.4 Home
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Production and Capacity Analysis
  • 2.1.1 Global Devices for Inhaled Medications Production Value 2014-2025
  • 2.1.2 Global Devices for Inhaled Medications Production 2014-2025
  • 2.1.3 Global Devices for Inhaled Medications Capacity 2014-2025
  • 2.1.4 Global Devices for Inhaled Medications Marketing Pricing and Trends
• 2.2 Key Producers Growth Rate (CAGR) 2019-2025
  • 2.2.1 Global Devices for Inhaled Medications Market Size CAGR of Key Regions
  • 2.2.2 Global Devices for Inhaled Medications Market Share of Key Regions
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Capacity and Production by Manufacturers
  • 3.1.1 Global Devices for Inhaled Medications Capacity by Manufacturers
  • 3.1.2 Global Devices for Inhaled Medications Production by Manufacturers
• 3.2 Revenue by Manufacturers
  • 3.2.1 Devices for Inhaled Medications Revenue by Manufacturers (2014-2019)
  • 3.2.2 Devices for Inhaled Medications Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Devices for Inhaled Medications Market Concentration Ratio (CR5 and HHI)
• 3.3 Devices for Inhaled Medications Price by Manufacturers
• 3.4 Key Manufacturers Devices for Inhaled Medications Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Devices for Inhaled Medications Market
• 3.6 Key Manufacturers Devices for Inhaled Medications Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Production and Production Value for Each Type
  • 4.1.1 Dry Powder Inhalers Production and Production Value (2014-2019)
  • 4.1.2 Metered-Dose Inhalers Production and Production Value (2014-2019)
  • 4.1.3 Nebulizers Production and Production Value (2014-2019)
  • 4.1.4 Soft Mist Inhaler Production and Production Value (2014-2019)
• 4.2 Global Devices for Inhaled Medications Production Market Share by Type
• 4.3 Global Devices for Inhaled Medications Production Value Market Share by Type
• 4.4 Devices for Inhaled Medications Ex-factory Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Devices for Inhaled Medications Consumption by Application

6 Production by Regions

• 6.1 Global Devices for Inhaled Medications Production (History Data) by Regions 2014-2019
• 6.2 Global Devices for Inhaled Medications Production Value (History Data) by Regions
• 6.3 United States
  • 6.3.1 United States Devices for Inhaled Medications Production Growth Rate 2014-2019
  • 6.3.2 United States Devices for Inhaled Medications Production Value Growth Rate 2014-2019
  • 6.3.3 Key Players in United States
  • 6.3.4 United States Devices for Inhaled Medications Import & Export
• 6.4 European Union
  • 6.4.1 European Union Devices for Inhaled Medications Production Growth Rate 2014-2019
  • 6.4.2 European Union Devices for Inhaled Medications Production Value Growth Rate 2014-2019
  • 6.4.3 Key Players in European Union
  • 6.4.4 European Union Devices for Inhaled Medications Import & Export
• 6.5 China
  • 6.5.1 China Devices for Inhaled Medications Production Growth Rate 2014-2019
  • 6.5.2 China Devices for Inhaled Medications Production Value Growth Rate 2014-2019
  • 6.5.3 Key Players in China
  • 6.5.4 China Devices for Inhaled Medications Import & Export
• 6.6 Rest of World
  • 6.6.1 Japan
  • 6.6.2 Korea
  • 6.6.3 India
  • 6.6.4 Southeast Asia

7 Devices for Inhaled Medications Consumption by Regions

• 7.1 Global Devices for Inhaled Medications Consumption (History Data) by Regions
• 7.2 United States
  • 7.2.1 United States Devices for Inhaled Medications Consumption by Type
  • 7.2.2 United States Devices for Inhaled Medications Consumption by Application
• 7.3 European Union
  • 7.3.1 European Union Devices for Inhaled Medications Consumption by Type
  • 7.3.2 European Union Devices for Inhaled Medications Consumption by Application
• 7.4 China
  • 7.4.1 China Devices for Inhaled Medications Consumption by Type
  • 7.4.2 China Devices for Inhaled Medications Consumption by Application
• 7.5 Rest of World
  • 7.5.1 Rest of World Devices for Inhaled Medications Consumption by Type
  • 7.5.2 Rest of World Devices for Inhaled Medications Consumption by Application
  • 7.5.1 Japan
  • 7.5.2 Korea
  • 7.5.3 India
  • 7.5.4 Southeast Asia

8 Company Profiles

• 8.1 Consort Medical
  • 8.1.1 Consort Medical Company Details
  • 8.1.2 Company Description and Business Overview
  • 8.1.3 Production and Revenue of Devices for Inhaled Medications
  • 8.1.4 Devices for Inhaled Medications Product Introduction
  • 8.1.5 Consort Medical Recent Development
• 8.2 Inhalexper
  • 8.2.1 Inhalexper Company Details
  • 8.2.2 Company Description and Business Overview
  • 8.2.3 Production and Revenue of Devices for Inhaled Medications
  • 8.2.4 Devices for Inhaled Medications Product Introduction
  • 8.2.5 Inhalexper Recent Development
• 8.3 Cambridge Consultants
  • 8.3.1 Cambridge Consultants Company Details
  • 8.3.2 Company Description and Business Overview
  • 8.3.3 Production and Revenue of Devices for Inhaled Medications
  • 8.3.4 Devices for Inhaled Medications Product Introduction
  • 8.3.5 Cambridge Consultants Recent Development
• 8.4 Hovione
  • 8.4.1 Hovione Company Details
  • 8.4.2 Company Description and Business Overview
  • 8.4.3 Production and Revenue of Devices for Inhaled Medications
  • 8.4.4 Devices for Inhaled Medications Product Introduction
  • 8.4.5 Hovione Recent Development
• 8.5 Catalent, Inc
  • 8.5.1 Catalent, Inc Company Details
  • 8.5.2 Company Description and Business Overview
  • 8.5.3 Production and Revenue of Devices for Inhaled Medications
  • 8.5.4 Devices for Inhaled Medications Product Introduction
  • 8.5.5 Catalent, Inc Recent Development
• 8.6 VertMarkets, Inc
  • 8.6.1 VertMarkets, Inc Company Details
  • 8.6.2 Company Description and Business Overview
  • 8.6.3 Production and Revenue of Devices for Inhaled Medications
  • 8.6.4 Devices for Inhaled Medications Product Introduction
  • 8.6.5 VertMarkets, Inc Recent Development
• 8.7 Qualicaps
  • 8.7.1 Qualicaps Company Details
  • 8.7.2 Company Description and Business Overview
  • 8.7.3 Production and Revenue of Devices for Inhaled Medications
  • 8.7.4 Devices for Inhaled Medications Product Introduction
  • 8.7.5 Qualicaps Recent Development
• 8.8 3M
  • 8.8.1 3M Company Details
  • 8.8.2 Company Description and Business Overview
  • 8.8.3 Production and Revenue of Devices for Inhaled Medications
  • 8.8.4 Devices for Inhaled Medications Product Introduction
  • 8.8.5 3M Recent Development
• 8.9 Aerovance
  • 8.9.1 Aerovance Company Details
  • 8.9.2 Company Description and Business Overview
  • 8.9.3 Production and Revenue of Devices for Inhaled Medications
  • 8.9.4 Devices for Inhaled Medications Product Introduction
  • 8.9.5 Aerovance Recent Development
• 8.10 AstraZeneca
  • 8.10.1 AstraZeneca Company Details
  • 8.10.2 Company Description and Business Overview
  • 8.10.3 Production and Revenue of Devices for Inhaled Medications
  • 8.10.4 Devices for Inhaled Medications Product Introduction
  • 8.10.5 AstraZeneca Recent Development
• 8.11 Boehringer Ingelheim
• 8.12 Chiesi
• 8.13 Cipla
• 8.14 Civitas/Alkermes
• 8.15 GlaxoSmithKline
• 8.16 Hovione
• 8.17 Mannkind
• 8.18 Mantecorp
• 8.19 Meda
• 8.20 MicroDose Therapeutx
• 8.21 Novartis

9 Market Forecast

• 9.1 Global Market Size Forecast
  • 9.1.1 Global Devices for Inhaled Medications Capacity, Production Forecast 2019-2025
  • 9.1.2 Global Devices for Inhaled Medications Production Value Forecast 2019-2025
• 9.2 Market Forecast by Regions
  • 9.2.1 Global Devices for Inhaled Medications Production and Value Forecast by Regions 2019-2025
  • 9.2.2 Global Devices for Inhaled Medications Consumption Forecast by Regions 2019-2025
• 9.3 United States
  • 9.3.1 Production and Value Forecast in United States
  • 9.3.2 Consumption Forecast in United States
• 9.4 European Union
  • 9.4.1 Production and Value Forecast in European Union
  • 9.4.2 Consumption Forecast in European Union
• 9.5 China
  • 9.5.1 Production and Value Forecast in China
  • 9.5.2 Consumption Forecast in China
• 9.6 Rest of World
  • 9.6.1 Japan
  • 9.6.2 Korea
  • 9.6.3 India
  • 9.6.4 Southeast Asia
• 9.7 Forecast by Type
  • 9.7.1 Global Devices for Inhaled Medications Production Forecast by Type
  • 9.7.2 Global Devices for Inhaled Medications Production Value Forecast by Type
• 9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis

• 10.1 Value Chain Analysis
• 10.2 Sales Channels Analysis
  • 10.2.1 Devices for Inhaled Medications Sales Channels
  • 10.2.2 Devices for Inhaled Medications Distributors
• 10.3 Devices for Inhaled Medications Customers

11 Opportunities & Challenges, Threat and Affecting Factors

• 11.1 Market Opportunities
• 11.2 Market Challenges
• 11.3 Porter's Five Forces Analysis

12 Key Findings

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details